US EditionMore Dorset Patients to Access 'Transformative' Cancer Vaccine
ENGLAND, AUG 7 – More than 100 patients with aggressive HPV-related head and neck cancers will be enrolled in a trial using mRNA technology to boost immune response, NHS England said.
- Patients in England diagnosed with head and neck cancer are being prioritized for enrollment in the AHEAD-MERIT clinical trial, which tests a promising new mRNA vaccine starting immediately.
- This plan follows NHS collaboration with BioNTech and builds on the Cancer Vaccine Launch Pad, which has already referred about 550 patients to other cancer vaccine trials.
- The AHEAD-MERIT trial will take place over the coming year at 15 NHS hospitals, aiming to enroll over 100 patients with advanced, aggressive cancers of the head and neck linked to HPV infection.
- Karin Smyth, the Health Minister, hailed the initiative as a significant achievement for cancer patients, highlighting that these vaccines have the potential to transform treatment and position the NHS as a leader in medical innovation.
- This trial offers renewed hope for difficult-to-treat cancers with low survival rates, and it reflects efforts to improve outcomes for over 11,000 new head and neck cancer cases diagnosed annually in England.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
Evening Standard+2 Reposted by 2 other sources
Patients to be fast-tracked on to new head and neck cancer vaccine trial
The jab uses mRNA technology to train the immune system to fight cancer.
·London, United Kingdom
Read Full Article
NUH to offer NHS cancer vaccine trial for patients with head and neck cancer
Nottingham University Hospitals NHS Trust (NUH) is one of just 15 hospitals in England to be involved in a new cancer vaccine trial in which patients with advanced head and neck cancers will be fast-tracked. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus […]
NHS fast-tracks mRNA vaccine trial for advanced head and neck cancer patients
NHS England is fast-tracking an mRNA vaccine trial for advanced head and neck cancer, offering new hope for patients. Find out more. The post NHS fast-tracks mRNA vaccine trial for advanced head and neck cancer patients appeared first on Innovation News Network.
Coverage Details
Total News Sources11
Leaning Left2Leaning Right0Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
